Good afternoon, ladies and gentlemen and welcome to the Vistagen Therapeutics fiscal year 2025, second-quarter corporate update conference call. (Operator Instructions) I would now like to turn the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback